Ralf Stemkens

8PUBLICATIONS
10CO-AUTHORS
Medical bacteriologyMedical mycologyQuality assurance, chemometrics, traceability and metrological chemistryPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 13, 2026
Exposure to azithromycin and the effect of co-administration of rifampicin in patients with non-tuberculous mycobacterial disease.

|Nov 10, 2025
Enhanced antimycobacterial efficacy of simulated inhaled clofazimine versus oral clofazimine in combination with azithromycin and ethambutol in a hollow-fiber system.

Jelmer Raaijmakers, Rob Aarnoutse, Lindsey Te Brake

|May 07, 2025
Bedaquiline does not enhance a clofazimine-azithromycin-ethambutol regimen against Mycobacterium avium in the hollow-fiber system.

J Raaijmakers, S Salillas, R Aarnoutse

|Oct 08, 2024
A loading dose of clofazimine to rapidly achieve steady-state-like concentrations in patients with nontuberculous mycobacterial disease.

Ralf Stemkens, Arthur Lemson, Simon E Koele

|Apr 06, 2024
Ten-year results of an international external quality control programme for measurement of anti-tuberculosis drug concentrations.

Ralf Stemkens, Chaima Mouhdad, Eric J F Franssen

|Jan 23, 2024
Clofazimine as a substitute for rifampicin improves efficacy of Mycobacterium avium pulmonary disease treatment in the hollow-fiber model.

Sandra Salillas, Jelmer Raaijmakers, Rob E Aarnoutse

Pageof 2

Frequent Collaborators

6 joint publications

Jakko van Ingen

3 joint publications

Jelmer Raaijmakers

2 joint publications

Reinout van Crevel

1 joint publications

M P Rodgers